AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32409944 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy without bevacizumab (Non-BEV)
Number of subjects: 61
Study 32409944 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV) treatment in first order recurrence
Number of subjects: 61
Study 32409944 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy without bevacizumab (Non-BEV) in first order recurrence
Number of subjects: 61
Study 32409944 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV) treatment in second or higher order recurrence
Number of subjects: 61
Study 32409944 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy without bevacizumab (Non-BEV) in second or higher order recurrence
Number of subjects: 61
Study 32409944 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV) overall survival multivariate analysis
Number of subjects: 61
Study 32141785 — intervention group
Group type: EXPERIMENTAL
Intervention: 585 nm Pulsed Dye Laser (PDL)
Number of subjects: 30
Study 34001166 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomaltulose
Number of subjects: 21
Study 34001166 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin
Number of subjects: 21
Study 34001166 — intervention group
Group type: COMPARATOR
Intervention: Glucose
Number of subjects: 21
Study 35130291 — intervention group
Group type: EXPERIMENTAL
Intervention: BCD‐057
Number of subjects: 346
Study 35130291 — intervention group
Group type: COMPARATOR
Intervention: iADA
Number of subjects: 346
Study 35130291 — intervention group
Group type: COMPARATOR
Intervention: iADA/BCD‐057
Number of subjects: 346
Study 35130291 — intervention group
Group type: COMPARATOR
Intervention: BCD‐057 and iADA
Number of subjects: 346
Study 35130291 — intervention group
Group type: COMPARATOR
Intervention: iADA to BCD‐057 switch
Number of subjects: 346
Study 34623254 — intervention group
Group type: EXPERIMENTAL
Intervention: Del Nido cardioplegia
Number of subjects: 300
Study 34623254 — intervention group
Group type: COMPARATOR
Intervention: Microplegia
Number of subjects: 300
Study 35768103 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT)
Number of subjects: 60
Study 35768103 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine rehabilitation training (RRT)
Number of subjects: 60
Study 35768103 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 60
Study 33932804 — intervention group
Group type: EXPERIMENTAL
Intervention: Sardine group (SG) - 200 g of sardine per week
Number of subjects: 152
Study 33932804 — intervention group
Group type: EXPERIMENTAL
Intervention: Sardine group (SG)
Number of subjects: 152
Study 32622225 — intervention group
Group type: EXPERIMENTAL
Intervention: Triage training for registered nurses and medical officer assistants
Number of subjects: 143
Study 32601978 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (participants recalled other recently consumed foods to increase salience of dietary variety)
Number of subjects: 139
Study 32601978 — intervention group
Group type: COMPARATOR
Intervention: Control group (participants recalled variety in an unrelated domain, music)
Number of subjects: 139
Study 32315444 — intervention group
Group type: EXPERIMENTAL
Intervention: Delmopinol hydrochloride (DEL)
Number of subjects: 89
Study 32315444 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine digluconate (CHX)
Number of subjects: 89
Study 32315444 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 89
Study 35843287 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear fluids + 2 L of polyethylene glycol (PEG) 12 hours before CE (Arm B)
Number of subjects: 229
Study 35843287 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear fluids + 1 L PEG + sodium ascorbate 3 hours before CE (Arm C)
Number of subjects: 229
Study 32140989 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course antibiotic therapy (≤ 10 days)
Number of subjects: 31
Study 32140989 — intervention group
Group type: COMPARATOR
Intervention: Long-course antibiotic therapy (28 days)
Number of subjects: 31
Study 35016059 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecologically realistic training based on pretend play (20 play sessions over 10 weeks)
Number of subjects: 70
Study 35016059 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 70
Study 33040829 — intervention group
Group type: EXPERIMENTAL
Intervention: Guizhi Fuling Pills (L, M, H groups)
Number of subjects: 0
Study 33040829 — intervention group
Group type: COMPARATOR
Intervention: Control group (Con)
Number of subjects: 0
Study 35749387 — intervention group
Group type: EXPERIMENTAL
Intervention: Health warning messages
Number of subjects: 1199
Study 35749387 — intervention group
Group type: COMPARATOR
Intervention: Environmental warning messages
Number of subjects: 1199
Study 34900568 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 0
Study 34900568 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33631978 — intervention group
Group type: EXPERIMENTAL
Intervention: Notebook covers illustrated with figures and informative texts about tooth avulsion and replantation
Number of subjects: 242
Study 32737664 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% chlorhexidine (CHX) and 0.05% cetylpyridinium chloride (CPC) mouth rinse
Number of subjects: 54
Study 32737664 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 54
Study 33186451 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 min of light-intensity walking every 30 minutes
Number of subjects: 18
Study 33186451 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 minutes of moderate-intensity walking every 30 minutes
Number of subjects: 18
Study 33186451 — intervention group
Group type: COMPARATOR
Intervention: Prolonged sitting
Number of subjects: 18
Study 34246118 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide (100–400 mg/day)
Number of subjects: 473
Study 36304175 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral saline administration (5 mL·kg−1 of normal saline 2 hours before anesthesia)
Number of subjects: 76
Study 36304175 — intervention group
Group type: COMPARATOR
Intervention: Control group (forbidden from drinking 8 hours prior to the operation)
Number of subjects: 76
Study 34803922 — intervention group
Group type: EXPERIMENTAL
Intervention: TyG index
Number of subjects: 9323
Study 616774896 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular electrical stimulation (VES) combined with medical treatment; 30 min long, twice a day, three times a week, for 12 sessions at 80 Hz TENS.
Number of subjects: 19
Study 616774896 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment only (control group).
Number of subjects: 19
Study 33039288 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus Anterior Plane Block (SAPB)
Number of subjects: 40
Study 33039288 — intervention group
Group type: COMPARATOR
Intervention: Intercostal Nerve Block (ICNB)
Number of subjects: 40
Study 35901339 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (800 mg twice daily)
Number of subjects: 33
Study 35901339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 33393610 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Laryngoscopy (VL)
Number of subjects: 50
Study 33393610 — intervention group
Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 50
Study 616062932 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic (EPA) and docosahexaenoic (DHA) polyunsaturated fatty acids supplementation (2.4g/d, 1.6 g EPA and 0.8 g DHA, ratio 2:1)
Number of subjects: 44
Study 616062932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 37244573 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate glue plus cord-anchored suture (SG group)
Number of subjects: 0
Study 37244573 — intervention group
Group type: COMPARATOR
Intervention: Suture alone (S group)
Number of subjects: 0
Study 37244573 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SG and S)
Number of subjects: 0
Study 33865303 — intervention group
Group type: EXPERIMENTAL
Intervention: LDC cream (3% Defensil®, 5% dexpanthenol and ceramide)
Number of subjects: 38
Study 33865303 — intervention group
Group type: COMPARATOR
Intervention: 5% urea cream
Number of subjects: 38
Study 33865303 — intervention group
Group type: EXPERIMENTAL
Intervention: LDC cream
Number of subjects: 38
Study 33865303 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study 34312153 — intervention group
Group type: EXPERIMENTAL
Intervention: Kilkari maternal messaging programme
Number of subjects: 4423
Study 34312153 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 4423
Study 32632894 — intervention group
Group type: EXPERIMENTAL
Intervention: Temozolomide plus short-course radiotherapy
Number of subjects: 562
Study 32632894 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 562
Study 35759691 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide at 20 ppm delivered into the cardiopulmonary bypass oxygenator (n=679)
Number of subjects: 1371
Study 35759691 — intervention group
Group type: COMPARATOR
Intervention: Standard care cardiopulmonary bypass without nitric oxide (n=685)
Number of subjects: 1371
Study 35759691 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide group
Number of subjects: 1371
Study 35759691 — intervention group
Group type: COMPARATOR
Intervention: Standard care group
Number of subjects: 1371
Study 34519661 — intervention group
Group type: EXPERIMENTAL
Intervention: Germ Defence intervention (open access website)
Number of subjects: 9779
Study 34519661 — intervention group
Group type: COMPARATOR
Intervention: RCT intervention (automated digital intervention)
Number of subjects: 9779
Study 34519661 — intervention group
Group type: EXPERIMENTAL
Intervention: Germ Defence intervention
Number of subjects: 9779
Study 34519661 — intervention group
Group type: COMPARATOR
Intervention: RCT intervention
Number of subjects: 9779
Study 32899117 — intervention group
Group type: EXPERIMENTAL
Intervention: hsa‐mir‐3614‐5p
Number of subjects: 14
Study 35535242 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided QLB with 20 ml of 0.375% ropivacaine
Number of subjects: 84
Study 35535242 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 84
Study 33016996 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 903
Study 33016996 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 903
Study 33016996 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid within 1 hour of injury
Number of subjects: 903
Study 33016996 — intervention group
Group type: COMPARATOR
Intervention: Placebo after 1 hour of injury
Number of subjects: 903
Study 33016996 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid in severe shock (systolic blood pressure ≤70 mm Hg)
Number of subjects: 903
Study 33016996 — intervention group
Group type: COMPARATOR
Intervention: Placebo in severe shock (systolic blood pressure ≤70 mm Hg)
Number of subjects: 903
Study 34344482 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact loading exercises added to standard pulmonary rehabilitation programme (PRP)
Number of subjects: 58
Study 34344482 — intervention group
Group type: COMPARATOR
Intervention: Standard pulmonary rehabilitation programme (PRP)
Number of subjects: 58
Study 34344482 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact loading exercises
Number of subjects: 58
Study 34344482 — intervention group
Group type: COMPARATOR
Intervention: Standard maintenance exercises
Number of subjects: 58
Study 34920451 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 100 score (predictive score for moderate-severe cGVHD)
Number of subjects: 1292
Study 34920451 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 100 score (predictive score for transplant-related mortality)
Number of subjects: 1292
Study 34920451 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 100 score (predictive score for survival)
Number of subjects: 1292
Study 34264696 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based mobile health (mHealth) intervention
Number of subjects: 114
Study 34264696 — intervention group
Group type: COMPARATOR
Intervention: Social support-based mHealth control
Number of subjects: 114
Study 33484240 — intervention group
Group type: EXPERIMENTAL
Intervention: EaseVRx (immersive pain relief skills VR program)
Number of subjects: 179
Study 33484240 — intervention group
Group type: COMPARATOR
Intervention: Sham VR (2D nature content delivered in a VR headset)
Number of subjects: 179
Study 32087121 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 2397
Study 32087121 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin emollients (skin intervention group)
Number of subjects: 2397
Study 32087121 — intervention group
Group type: EXPERIMENTAL
Intervention: Early complementary feeding (food intervention group)
Number of subjects: 2397
Study 32087121 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined skin and food interventions (combined intervention group)
Number of subjects: 2397
Study 32274492 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride tooth protector combined with pit and fissure sealant
Number of subjects: 200
Study 32274492 — intervention group
Group type: COMPARATOR
Intervention: Pit and fissure sealant alone
Number of subjects: 200
Study 35750321 — intervention group
Group type: EXPERIMENTAL
Intervention: Anchoring-endoscopic mucosal resection (A-EMR)
Number of subjects: 211
Study 35750321 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopic mucosal resection (C-EMR)
Number of subjects: 211
Study 34622680 — intervention group
Group type: COMPARATOR
Intervention: Low-volume centers
Number of subjects: 1032
Study 34622680 — intervention group
Group type: COMPARATOR
Intervention: Intermediate-volume centers
Number of subjects: 1032
Study 34622680 — intervention group
Group type: COMPARATOR
Intervention: High-volume centers
Number of subjects: 1032
Study 36373323 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR light treatment (1060-1080 nm and 800-820 nm) for 12 weeks
Number of subjects: 20
Study 34339475 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-minute walk test (6MWT)
Number of subjects: 92
Study 34339475 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, sex, mRS, and 6MWT
Number of subjects: 92
Study 34339475 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily physical activity
Number of subjects: 92
Study 32498216 — intervention group
Group type: EXPERIMENTAL
Intervention: Difensil Immuno (DI) 10 mL for 90 days
Number of subjects: 120
Study 32498216 — intervention group
Group type: EXPERIMENTAL
Intervention: Difensil Immuno (DI) 15 mL for 45 days
Number of subjects: 120
Study 32498216 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 34633141 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based nursing intervention for 6 weeks
Number of subjects: 120
Study 34633141 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 120
Study 32475902 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide-based combination therapy with alogliptin
Number of subjects: 18
Study 32475902 — intervention group
Group type: COMPARATOR
Intervention: Miglitol-based combination therapy with alogliptin
Number of subjects: 18
Study 32475902 — intervention group
Group type: COMPARATOR
Intervention: Repaglinide monotherapy
Number of subjects: 18
Study 32475902 — intervention group
Group type: COMPARATOR
Intervention: Miglitol monotherapy
Number of subjects: 18
Study 32475902 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with alogliptin
Number of subjects: 18
Study 32868595 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm Breastfeeding Assessment Tool (PBAT)
Number of subjects: 60
Study 35945634 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (two times a week for 6 weeks)
Number of subjects: 100
Study 35945634 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 100
Study 33769243 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnCl2 (1.5 µg/ml)
Number of subjects: 0
Study 33769243 — intervention group
Group type: EXPERIMENTAL
Intervention: Na2SeO3 (5 µg/l)
Number of subjects: 0
Study 33769243 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnCl2 + Na2SeO3 (1.5 µg/ml + 5 µg/l)
Number of subjects: 0
Study 33769243 — intervention group
Group type: COMPARATOR
Intervention: Control maturation medium (basic medium)
Number of subjects: 0
Study 32902561 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-lung ventilation (recruitment maneuvers, PEEP = 8 cm H2O, low-tidal volume)
Number of subjects: 86
Study 32902561 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-lung ventilation
Number of subjects: 86
Study 35747142 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (Engerix‐B, 20 μg/time) administered subcutaneously/intramuscularly at weeks 0, 4, and 24
Number of subjects: 200
Study 35747142 — intervention group
Group type: COMPARATOR
Intervention: Control group (blank control)
Number of subjects: 200
Study 35747142 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (Engerix‐B)
Number of subjects: 200
Study 34962665 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + diode laser (0.80W power, 940nm wavelength and 0.80J/s energy level)
Number of subjects: 40
Study 34962665 — intervention group
Group type: COMPARATOR
Intervention: SRP
Number of subjects: 40
Study 35468736 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT) program, 9 weeks
Number of subjects: 20
Study 33031265 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block with ropivacaine (Group A)
Number of subjects: 60
Study 33031265 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 60
Study 33495545 — intervention group
Group type: EXPERIMENTAL
Intervention: MDD participants
Number of subjects: 109
Study 33495545 — intervention group
Group type: COMPARATOR
Intervention: Placebo response in a sham-controlled trial of high-frequency repetitive transcranial magnetic stimulation
Number of subjects: 109
Study 32807234 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 0
Study 32807234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35818255 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint process location slip technique combined with percutaneous endoscopic lumbar disc discectomy
Number of subjects: 290
Study 35818255 — intervention group
Group type: COMPARATOR
Intervention: Traditional intervertebral fenestration of nucleus pulposus
Number of subjects: 290
Study 32511792 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic clipping (PC)
Number of subjects: 1080
Study 32511792 — intervention group
Group type: COMPARATOR
Intervention: Non-prophylactic clipping (non-PC)
Number of subjects: 1080
Study 32360105 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight‐adjustable treadmill
Number of subjects: 363
Study 32360105 — intervention group
Group type: EXPERIMENTAL
Intervention: Recumbent bike and use of a patterned electrical neuromuscular stimulation device
Number of subjects: 363
Study 32360105 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight‐adjustable treadmill and a patterned electrical neuromuscular stimulation device
Number of subjects: 363
Study 32360105 — intervention group
Group type: COMPARATOR
Intervention: Stationary recumbent bike (control intervention)
Number of subjects: 363
Study 34416294 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg
Number of subjects: 798
Study 34416294 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg
Number of subjects: 798
Study 34416294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 798
Study 32283941 — intervention group
Group type: EXPERIMENTAL
Intervention: Collar (N = 72)
Number of subjects: 128
Study 32283941 — intervention group
Group type: COMPARATOR
Intervention: Non-collar (N = 56)
Number of subjects: 128
Study 35725362 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet group
Number of subjects: 80
Study 35725362 — intervention group
Group type: COMPARATOR
Intervention: Non‐tourniquet group
Number of subjects: 80
Study 35175908 — intervention group
Group type: EXPERIMENTAL
Intervention: Teach-back method for breastfeeding education
Number of subjects: 80
Study 35175908 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 80
Study 34193288 — intervention group
Group type: EXPERIMENTAL
Intervention: e-cigarette
Number of subjects: 49
Study 34193288 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 49
Study 34193288 — intervention group
Group type: EXPERIMENTAL
Intervention: Both e-cigarette and NRT
Number of subjects: 49
Study 34193288 — intervention group
Group type: EXPERIMENTAL
Intervention: STOP intervention
Number of subjects: 49
Study 35312136 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine 80 mg daily
Number of subjects: 30
Study 35312136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32620143 — intervention group
Group type: EXPERIMENTAL
Intervention: fructooligosaccharides
Number of subjects: 80
Study 32620143 — intervention group
Group type: EXPERIMENTAL
Intervention: polydextrose
Number of subjects: 80
Study 34027686 — intervention group
Group type: EXPERIMENTAL
Intervention: BAILAMOSTM dance program
Number of subjects: 57
Study 34027686 — intervention group
Group type: COMPARATOR
Intervention: Health education (HE)
Number of subjects: 57
Study 34040361 — intervention group
Group type: EXPERIMENTAL
Intervention: Stentoplasty with calcium sulfate/calcium phosphate (CSCP) composite filler
Number of subjects: 42
Study 34040361 — intervention group
Group type: EXPERIMENTAL
Intervention: Stentoplasty with hydroxyapatite/collagen (HAP/COL) composite filler
Number of subjects: 42
Study 34040361 — intervention group
Group type: COMPARATOR
Intervention: Balloon kyphoplasty (BKP) with polymethylmethacrylate (PMMA)
Number of subjects: 42
Study 32533295 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-Delivered Parent-Child Interaction Therapy (iPCIT)
Number of subjects: 40